Power Law company profile

HeartFlow

Biotech & Life Sciences · Redwood City, United States · Founded 2007 · IPO 2025 Unicorn

A non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease

Valuation

$2.41B

Market cap · May/2026

Revenue

$176M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

14 investors on HeartFlow's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 3 investors entered at this stage

Emergent Medical Partners

U.S. Venture Partners

HealthCor Partners

Series B+ 11 investors entered at this stage

Bain Capital Life Sciences

Hayfin Capital Management

Capricorn Investment Group

Panorama Point Partners

Martis Capital

Rancilio Cube

Baillie Gifford

Wellington Management

Janus Henderson Investors

Fidelity Investments

Sandbox Industries

Global footprint

Where HeartFlow has talent and traffic

AI talent share

1.6% of workforce is AI talent
(13 of 810 staff)

Core AI91.11%

Other AI40.49%

Non-AI workforce79798.4%

Workforce by country

9 countries with
team presence

🇺🇸 United States95.6%

🇬🇧 United Kingdom2.1%

🇨🇦 Canada0.6%

🇯🇵 Japan0.6%

🇳🇱 Netherlands0.2%

Top 5 of 9 shown

Web traffic by country

90K monthly visits
across markets

🇺🇸 United States87.6%

🇯🇵 Japan3%

🏳️ Korea2.1%

🏳️ Republic of1.9%

🇮🇳 India1.8%

Top 5 markets shown

Patent intelligence

$247M patent portfolio · 97 active families

Estimated portfolio value

$247M

10.2% of market cap · 2.5× the top peer Silk Road Medical ($97M)

97 active patent families

Where HeartFlow innovates Blood vesselComputer visionRadiologyNuclear medicineBlood flow

Where HeartFlow concentrates vs peers

Each axis is a top-10 topic across HeartFlow and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about HeartFlow

An AI-synthesized read of the highest-engagement posts about HeartFlow on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See HeartFlow on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles